Treatment of Axillosubclavian Vein Thrombosis: A Novel Technique for Rapid Removal of Clot Using Low-Dose Thrombolysis

Frank R. Arko, Paul Cipriano, Eugene S Lee, Konstantinos A. Filis, Christopher K. Zarins, Thomas J. Fogarty

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Purpose: To report successful combined percutaneous mechanical thrombectomy and pharmacological lysis for axillosubclavian vein thrombosis, with rapid clot removal at a single setting using low-dose thrombolysis. Case Reports: Two consecutive patients presented with arm swelling; the diagnosis of axillosubclavian vein thrombosis was confirmed with duplex ultrasound. Both patients were treated percutaneously with the Solera mechanical thrombectomy device, after which 5 mg of tissue plasminogen activator were delivered within ∼10 minutes via the Trellis infusion catheter to remove any residual thrombus. Completion venography and serial duplex ultrasound scans in follow-up demonstrated widely patent axillosubclavian veins with no residual thrombus in both cases. Conclusions: Standard treatment of axillosubclavian vein thrombosis may require 12 to 36 hours, with multiple trips to the angiography suite. The novel technique combining mechanical thrombectomy and pharmacological lysis can be performed safely and successfully at a single setting with a small dose of the lytic drug.

Original languageEnglish (US)
Pages (from-to)733-738
Number of pages6
JournalJournal of Endovascular Therapy
Volume10
Issue number4
DOIs
StatePublished - Aug 2003
Externally publishedYes

Fingerprint

Veins
Thrombosis
Thrombectomy
Pharmacology
Therapeutics
Phlebography
Tissue Plasminogen Activator
Angiography
Catheters
Equipment and Supplies
Pharmaceutical Preparations

Keywords

  • Axillosubclavian vein
  • Mechanical thrombectomy
  • Solera Bacchus Thrombectomy Catheter
  • Thrombolysis
  • Tissue plasminogen activator
  • Trellis Infusion System
  • Upper extremity vein thrombosis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Treatment of Axillosubclavian Vein Thrombosis : A Novel Technique for Rapid Removal of Clot Using Low-Dose Thrombolysis. / Arko, Frank R.; Cipriano, Paul; Lee, Eugene S; Filis, Konstantinos A.; Zarins, Christopher K.; Fogarty, Thomas J.

In: Journal of Endovascular Therapy, Vol. 10, No. 4, 08.2003, p. 733-738.

Research output: Contribution to journalArticle

Arko, Frank R. ; Cipriano, Paul ; Lee, Eugene S ; Filis, Konstantinos A. ; Zarins, Christopher K. ; Fogarty, Thomas J. / Treatment of Axillosubclavian Vein Thrombosis : A Novel Technique for Rapid Removal of Clot Using Low-Dose Thrombolysis. In: Journal of Endovascular Therapy. 2003 ; Vol. 10, No. 4. pp. 733-738.
@article{7dbbcc662c364fd6bdfc7bd07471c6de,
title = "Treatment of Axillosubclavian Vein Thrombosis: A Novel Technique for Rapid Removal of Clot Using Low-Dose Thrombolysis",
abstract = "Purpose: To report successful combined percutaneous mechanical thrombectomy and pharmacological lysis for axillosubclavian vein thrombosis, with rapid clot removal at a single setting using low-dose thrombolysis. Case Reports: Two consecutive patients presented with arm swelling; the diagnosis of axillosubclavian vein thrombosis was confirmed with duplex ultrasound. Both patients were treated percutaneously with the Solera mechanical thrombectomy device, after which 5 mg of tissue plasminogen activator were delivered within ∼10 minutes via the Trellis infusion catheter to remove any residual thrombus. Completion venography and serial duplex ultrasound scans in follow-up demonstrated widely patent axillosubclavian veins with no residual thrombus in both cases. Conclusions: Standard treatment of axillosubclavian vein thrombosis may require 12 to 36 hours, with multiple trips to the angiography suite. The novel technique combining mechanical thrombectomy and pharmacological lysis can be performed safely and successfully at a single setting with a small dose of the lytic drug.",
keywords = "Axillosubclavian vein, Mechanical thrombectomy, Solera Bacchus Thrombectomy Catheter, Thrombolysis, Tissue plasminogen activator, Trellis Infusion System, Upper extremity vein thrombosis",
author = "Arko, {Frank R.} and Paul Cipriano and Lee, {Eugene S} and Filis, {Konstantinos A.} and Zarins, {Christopher K.} and Fogarty, {Thomas J.}",
year = "2003",
month = "8",
doi = "10.1583/1545-1550(2003)010<0733:TOAVTA>2.0.CO;2",
language = "English (US)",
volume = "10",
pages = "733--738",
journal = "Journal of Endovascular Therapy",
issn = "1526-6028",
publisher = "International Society of Endovascular Specialists",
number = "4",

}

TY - JOUR

T1 - Treatment of Axillosubclavian Vein Thrombosis

T2 - A Novel Technique for Rapid Removal of Clot Using Low-Dose Thrombolysis

AU - Arko, Frank R.

AU - Cipriano, Paul

AU - Lee, Eugene S

AU - Filis, Konstantinos A.

AU - Zarins, Christopher K.

AU - Fogarty, Thomas J.

PY - 2003/8

Y1 - 2003/8

N2 - Purpose: To report successful combined percutaneous mechanical thrombectomy and pharmacological lysis for axillosubclavian vein thrombosis, with rapid clot removal at a single setting using low-dose thrombolysis. Case Reports: Two consecutive patients presented with arm swelling; the diagnosis of axillosubclavian vein thrombosis was confirmed with duplex ultrasound. Both patients were treated percutaneously with the Solera mechanical thrombectomy device, after which 5 mg of tissue plasminogen activator were delivered within ∼10 minutes via the Trellis infusion catheter to remove any residual thrombus. Completion venography and serial duplex ultrasound scans in follow-up demonstrated widely patent axillosubclavian veins with no residual thrombus in both cases. Conclusions: Standard treatment of axillosubclavian vein thrombosis may require 12 to 36 hours, with multiple trips to the angiography suite. The novel technique combining mechanical thrombectomy and pharmacological lysis can be performed safely and successfully at a single setting with a small dose of the lytic drug.

AB - Purpose: To report successful combined percutaneous mechanical thrombectomy and pharmacological lysis for axillosubclavian vein thrombosis, with rapid clot removal at a single setting using low-dose thrombolysis. Case Reports: Two consecutive patients presented with arm swelling; the diagnosis of axillosubclavian vein thrombosis was confirmed with duplex ultrasound. Both patients were treated percutaneously with the Solera mechanical thrombectomy device, after which 5 mg of tissue plasminogen activator were delivered within ∼10 minutes via the Trellis infusion catheter to remove any residual thrombus. Completion venography and serial duplex ultrasound scans in follow-up demonstrated widely patent axillosubclavian veins with no residual thrombus in both cases. Conclusions: Standard treatment of axillosubclavian vein thrombosis may require 12 to 36 hours, with multiple trips to the angiography suite. The novel technique combining mechanical thrombectomy and pharmacological lysis can be performed safely and successfully at a single setting with a small dose of the lytic drug.

KW - Axillosubclavian vein

KW - Mechanical thrombectomy

KW - Solera Bacchus Thrombectomy Catheter

KW - Thrombolysis

KW - Tissue plasminogen activator

KW - Trellis Infusion System

KW - Upper extremity vein thrombosis

UR - http://www.scopus.com/inward/record.url?scp=0242331805&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242331805&partnerID=8YFLogxK

U2 - 10.1583/1545-1550(2003)010<0733:TOAVTA>2.0.CO;2

DO - 10.1583/1545-1550(2003)010<0733:TOAVTA>2.0.CO;2

M3 - Article

C2 - 14533970

AN - SCOPUS:0242331805

VL - 10

SP - 733

EP - 738

JO - Journal of Endovascular Therapy

JF - Journal of Endovascular Therapy

SN - 1526-6028

IS - 4

ER -